FDA and DEA warn over sale of misbranded opioid drugs

01-10-2019

Saman Javed

FDA and DEA warn over sale of misbranded opioid drugs

Jarretera / Shutterstock.com

The US Food and Drug Administration (FDA) and Drug Enforcement Administration (DEA) have issued joint warning letters to four online networks which allegedly sell unapproved and misbranded versions of medicines.


US Food and Drug Administration, Drug Enforcement Administration, opioid, counterfeit medicines, Tramadol, painkiller

LSIPR